X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2185) 2185
Publication (420) 420
Book Chapter (42) 42
Book Review (21) 21
Conference Proceeding (13) 13
Dissertation (3) 3
Book / eBook (2) 2
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1468) 1468
neurosciences (1031) 1031
index medicus (965) 965
humans (792) 792
male (776) 776
rats (714) 714
dopamine (522) 522
vesicular monoamine transporter (514) 514
vesicular monoamine transport proteins - metabolism (478) 478
dopamine - metabolism (442) 442
mice (436) 436
female (378) 378
membrane transport proteins (378) 378
vesicular biogenic amine transport proteins (370) 370
neurons (355) 355
biochemistry & molecular biology (354) 354
neuropeptides (337) 337
vesicular monoamine transport proteins (318) 318
article (313) 313
rats, sprague-dawley (309) 309
pharmacology & pharmacy (306) 306
parkinson's disease (265) 265
parkinsons-disease (264) 264
brain (254) 254
dopamine transporter (248) 248
brain - metabolism (229) 229
neurons - metabolism (216) 216
vesicular monoamine transporter-2 (212) 212
membrane glycoproteins - metabolism (209) 209
synaptic vesicles (206) 206
immunohistochemistry (205) 205
expression (203) 203
vesicular monoamine transport proteins - genetics (200) 200
serotonin (190) 190
tetrabenazine - analogs & derivatives (186) 186
neurology (182) 182
synaptic vesicles - metabolism (181) 181
corpus striatum - metabolism (177) 177
analysis (173) 173
vmat2 (172) 172
rat-brain (169) 169
tyrosine 3-monooxygenase - metabolism (163) 163
amphetamine (161) 161
positron-emission-tomography (161) 161
monoamine transporter (160) 160
nervous system (155) 155
cell biology (154) 154
clinical neurology (154) 154
dopamine plasma membrane transport proteins - metabolism (153) 153
methamphetamine (153) 153
mice, inbred c57bl (153) 153
psychiatry (153) 153
glutamate (149) 149
substantia-nigra (148) 148
adult (143) 143
middle aged (139) 139
in-vivo (138) 138
serotonin - metabolism (136) 136
vesicular amine transporter (135) 135
disease models, animal (132) 132
transporter (132) 132
phenols (131) 131
proteins (131) 131
release (130) 130
binding (126) 126
neurotransmitter agents - metabolism (125) 125
pc12 cells (122) 122
cocaine (121) 121
rats, wistar (120) 120
carrier proteins - metabolism (119) 119
gene expression (119) 119
physiological aspects (119) 119
dose-response relationship, drug (118) 118
neurotoxicity (117) 117
rat (116) 116
rodents (116) 116
vesicular monoamine transporter 2 (116) 116
positron emission tomography (115) 115
tyrosine-hydroxylase (114) 114
corpus striatum - drug effects (113) 113
vesicular acetylcholine transporter (112) 112
biological transport (111) 111
oxidative stress (111) 111
acetylcholine (110) 110
neurotransmitters (110) 110
cells, cultured (106) 106
research (106) 106
pet (105) 105
aged (104) 104
membrane glycoproteins - genetics (103) 103
tetrabenazine (103) 103
mice, knockout (102) 102
gaba (100) 100
vesicular monoamine transport proteins - antagonists & inhibitors (98) 98
molecular sequence data (97) 97
neurons - drug effects (96) 96
time factors (94) 94
brain - drug effects (93) 93
central-nervous-system (93) 93
neuroscience (92) 92
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2196) 2196
Japanese (7) 7
German (4) 4
Spanish (4) 4
French (2) 2
Chinese (1) 1
Korean (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


FEBS Letters, ISSN 0014-5793, 04/2011, Volume 585, Issue 7, pp. 1001 - 1006
Although well-studied in the context of neurodegenerative disease, a clear biological function for the synuclein proteins remains elusive. Emerging data... 
Mood disorder | Depression | Parkinson’s disease | Anti-depressant | norepinephrine | WIS | MAT | soluble N-ethylmaleimide-sensitive factor attachment protein receptor | Parkinson's disease | WKY | CNS | γ-synuclein | desipramine | SNARE | Synt-1 | Wistar rat | presynaptic plasma membrane monoamine transporters | α-Syn | syntaxin 1A | Wistar-Kyoto rat | VMAT2 | Alzheimer's disease | α-synuclein | DMI | vesicular monoamine transporter 2 | β-Syn | non-Aβ component of AD amyloid | central nervous system | NAC | β-synuclein | SERT | dopamine transporter | norepinephrine transporter | serotonin transporter | DAT | serotonin, 5-hydroxytryptamine | γ-Syn | NET | 5-HT | dopamine | CELLS | SEROTONIN TRANSPORTER | BIOCHEMISTRY & MOLECULAR BIOLOGY | ALPHA-SYNUCLEIN | DOPAMINE TRANSPORTER | SUBSTANTIA-NIGRA | MICE LACKING | CELL BIOLOGY | BIOPHYSICS | GAMMA-SYNUCLEIN | NOREPINEPHRINE TRANSPORTER | ANIMAL-MODEL | SYNTAXIN 1A | Animals | Synapses - metabolism | Catecholamine Plasma Membrane Transport Proteins - metabolism | Humans | Neurotransmitter Agents - biosynthesis | Biogenic Monoamines - biosynthesis | Biogenic Monoamines - metabolism | Synucleins - metabolism | Neurotransmitter Agents - secretion | Nervous system diseases | Antidepressants | Depression, Mental | Amyloid beta-protein | mood disorder | depression | anti-depressant
Journal Article
Journal Article
Trends in Neurosciences, ISSN 0166-2236, 2017, Volume 40, Issue 4, pp. 195 - 196
It is well established that glutamate and GABA signal through both ionotropic and metabotropic receptors. Conversely, it is thought that, with one exception,... 
Neurology | NEURONS | TRANSMISSION | DEPOLARIZATION | CHANNELS | DOPAMINE TRANSPORTER | NEUROSCIENCES | Neurons - metabolism | Receptors, Ionotropic Glutamate - metabolism | Animals | Vesicular Monoamine Transport Proteins - metabolism | Plasma Membrane Neurotransmitter Transport Proteins - metabolism | Physiological aspects | GABA | Glutamate
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2014, Volume 111, Issue 27, pp. 9977 - 9982
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 2013, Volume 34, Issue 6, pp. 1712.e9 - 1712.e13
Journal Article
Drugs, ISSN 0012-6667, 4/2018, Volume 78, Issue 5, pp. 525 - 541
Tardive dyskinesia (TD) encompasses the spectrum of iatrogenic hyperkinetic movement disorders following exposure to dopamine receptor-blocking agents (DRBAs).... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | MOVEMENT-DISORDERS | CONTROLLED-TRIAL | RISK-FACTORS | 2ND-GENERATION ANTIPSYCHOTICS | GINKGO-BILOBA | DOUBLE-BLIND | INDUCED EXTRAPYRAMIDAL SYNDROMES | PHARMACOLOGY & PHARMACY | TOXICOLOGY | RATING-SCALE | GENDER-DIFFERENCES | DRUG-INDUCED DYSKINESIA | Tetrabenazine - administration & dosage | Tetrabenazine - analogs & derivatives | Tardive Dyskinesia - drug therapy | Tourette Syndrome - drug therapy | United States | Antipsychotic Agents - adverse effects | Humans | Valine - analogs & derivatives | Vesicular Monoamine Transport Proteins - antagonists & inhibitors | Drug Approval | Valine - administration & dosage | Antipsychotic Agents - administration & dosage | Valine - chemistry | Antipsychotic Agents - chemistry | Antipsychotic Agents - therapeutic use | Tetrabenazine - chemistry | Valine - therapeutic use | Valine - adverse effects | Huntington Disease - drug therapy | Tetrabenazine - adverse effects | United States Food and Drug Administration | Tetrabenazine - therapeutic use | Drugs | Brain | Regulatory agencies | Neuroleptics | Deep brain stimulation | Medical services | Parkinsons disease | Disorders | Schizophrenia | Phenomenology | Psychotropic drugs | Metabolites | Gilles de la Tourette syndrome | Deuteration | Tardive dyskinesia | Movement disorders | Dyskinesia | Amantadine | Electroconvulsive therapy | Dopamine | Complications | Pharmacology | Tetrabenazine | FDA approval | Clonazepam | Vesicular amine transporter | Botulinum toxin | Side effects | Inhibitors | Monoamine transporter | Zolpidem | Psychiatry | Transporter
Journal Article